BRPI0507612A - análogos exibindo inibição de proliferação de célula e métodos para fabricação e uso destes - Google Patents
análogos exibindo inibição de proliferação de célula e métodos para fabricação e uso destesInfo
- Publication number
- BRPI0507612A BRPI0507612A BRPI0507612-9A BRPI0507612A BRPI0507612A BR PI0507612 A BRPI0507612 A BR PI0507612A BR PI0507612 A BRPI0507612 A BR PI0507612A BR PI0507612 A BRPI0507612 A BR PI0507612A
- Authority
- BR
- Brazil
- Prior art keywords
- cell proliferation
- methods
- making
- inhibition
- exhibiting inhibition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Epoxy Compounds (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54372404P | 2004-02-11 | 2004-02-11 | |
| US55580304P | 2004-03-24 | 2004-03-24 | |
| PCT/US2005/004759 WO2005086638A2 (en) | 2004-02-11 | 2005-02-11 | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0507612A true BRPI0507612A (pt) | 2007-07-03 |
Family
ID=34976061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0507612-9A BRPI0507612A (pt) | 2004-02-11 | 2005-02-11 | análogos exibindo inibição de proliferação de célula e métodos para fabricação e uso destes |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1723127A4 (ja) |
| JP (1) | JP2007522247A (ja) |
| AU (1) | AU2005220705A1 (ja) |
| BR (1) | BRPI0507612A (ja) |
| CA (1) | CA2559333A1 (ja) |
| EA (1) | EA200601471A1 (ja) |
| IL (1) | IL177444A0 (ja) |
| WO (1) | WO2005086638A2 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101395146B1 (ko) * | 2011-02-09 | 2014-05-16 | 부산대학교 산학협력단 | 피부미백, 항산화 및 ｐｐａｒ 활성을 갖는 신규 화합물 및 이의 의학적 용도 |
| WO2014066613A2 (en) * | 2012-10-26 | 2014-05-01 | Zhejiang University | Sphingolipid metabolite mimetics |
| EA030611B1 (ru) * | 2013-03-15 | 2018-08-31 | Кэнсер Рисерч Текнолоджи, Ллк | Способы и композиции для модуляции гамма-глутамилового цикла |
| WO2023170024A1 (en) * | 2022-03-11 | 2023-09-14 | University Of Copenhagen | Camk2 modulators and their use in medicine |
| CN115894398B (zh) * | 2022-12-02 | 2024-03-12 | 青岛科技大学 | 一种含氟噻唑酰胺类杀虫杀螨剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1017435B (zh) * | 1987-03-24 | 1992-07-15 | 日本化学医药株式会社 | 新的甘油衍生物的制备方法 |
| US4826990A (en) * | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
| US5149704A (en) * | 1991-05-03 | 1992-09-22 | Abbott Laboratories | Platelet activating antagonists |
| FR2678938B1 (fr) * | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
| FR2700168B1 (fr) * | 1993-01-07 | 1995-02-03 | Rhone Poulenc Rorer Sa | Dérivés de thiazolidine, leur préparation et les médicaments les contenant. |
| DE19546918A1 (de) * | 1995-12-15 | 1997-06-19 | Bayer Ag | Bicyclische Heterocyclen |
-
2005
- 2005-02-11 CA CA002559333A patent/CA2559333A1/en not_active Abandoned
- 2005-02-11 BR BRPI0507612-9A patent/BRPI0507612A/pt not_active IP Right Cessation
- 2005-02-11 JP JP2006553347A patent/JP2007522247A/ja not_active Withdrawn
- 2005-02-11 AU AU2005220705A patent/AU2005220705A1/en not_active Abandoned
- 2005-02-11 EP EP05749117A patent/EP1723127A4/en not_active Withdrawn
- 2005-02-11 WO PCT/US2005/004759 patent/WO2005086638A2/en active Search and Examination
- 2005-02-11 EA EA200601471A patent/EA200601471A1/ru unknown
-
2006
- 2006-08-10 IL IL177444A patent/IL177444A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL177444A0 (en) | 2006-12-10 |
| WO2005086638A2 (en) | 2005-09-22 |
| AU2005220705A1 (en) | 2005-09-22 |
| EP1723127A4 (en) | 2009-10-28 |
| EA200601471A1 (ru) | 2007-10-26 |
| CA2559333A1 (en) | 2005-09-22 |
| EP1723127A2 (en) | 2006-11-22 |
| WO2005086638A3 (en) | 2005-11-24 |
| JP2007522247A (ja) | 2007-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021018303A2 (pt) | Novos inibidores de pequenas moléculas de fatores de transcrição tead | |
| GT200500237A (es) | Derivados de pirimidina | |
| CR20150368A (es) | Inhibidores de histona desmetilasa | |
| ATE408412T1 (de) | Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration | |
| EA201201154A1 (ru) | Ингибиторы фосфатидилинозит-3-киназы и способы их применения | |
| EA200901074A1 (ru) | Лечение метастатической стадии рака предстательной железы дегареликсом | |
| CL2012002844A1 (es) | Compuestos derivados de cromen-2-ona; composicion farmaceutica que los comprende; y su uso en el tratamiento de un trastorno proliferativo de celulas tal como cancer (divisional solicitud nº 311-07). | |
| GT200800202A (es) | Quinazolinas para la inhibicion de pdk1 | |
| CL2010001624A1 (es) | Uso de compuestos derivados de bisfenol diglicidil para tratar el cancer de prostata; compuestos derivados de bisfenol diglicidil eter; y composicion farmaceutica que compprende el compuesto. | |
| WO2011087845A3 (en) | Metabolomic profiling of prostate cancer | |
| CL2008002982A1 (es) | Compuestos derivados de 4,5-difenil-imidazol sustituidos por heterociclos, inhibidores mdm2; composicion farmaceutica que los comprende; proceso de preparacion de los compuestos; y uso en el tratamiento del cancer de mama, colon, pulmon o prostata. | |
| MX2011007420A (es) | Compuestos, composiciones y metodos para prevenir la metastasis de las celulas cancerigenas. | |
| CO6630103A2 (es) | Fitocanabinoides en el tratamiento de cáncer | |
| CO6440529A2 (es) | Pirimidinonas como inhibidores de pi3k | |
| BRPI0923786C1 (pt) | compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos e composições farmacêuticas compreendendo ditos compostos | |
| BRPI0715176A8 (pt) | compostos de heteroarila utéis como inibidores de enzimas de ativação e1 | |
| RU2448096C3 (ru) | Диарилгидантоины | |
| CU20120042A7 (es) | (heteroarilmetil)tiohidantoínas sustituidas como drogas anticáncer | |
| GT200500229A (es) | Compuestos orgánicos | |
| CR11412A (es) | Inhibidores de cinesina como productos terapeuticos para el cancer | |
| EA201790502A1 (ru) | Ингибиторы гистоновых диметилаз | |
| WO2013152120A3 (en) | Compositions and methods for promoting intestinal stem cell function | |
| BRPI0507612A (pt) | análogos exibindo inibição de proliferação de célula e métodos para fabricação e uso destes | |
| MX2019011469A (es) | Inhibidores del mir-155 para tratar linfoma cutaneo de celulas t (ctcl). | |
| BR112013003579A2 (pt) | adenovírus, células, e, métodos para tratar câncer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A E 6A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011. |